Meta-Flux
The AI Biologist for smarter drug development
Dublin, Ireland · Founded 2024 · $2.1M raised
- Headquarters
- Dublin, Dublin
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- meta-flux.com
- Total Funding
- $2.1M
About
Meta-Flux is a Dublin-based biotech startup building an 'AI Biologist' for pharmaceutical drug development. The platform uses feedback-loop knowledge graphs and multi-scale simulation models to process 20+ trillion biological data points across genes, proteins, metabolites, and patient phenotypes. It enables pharma teams to run rapid hypothesis-to-insight cycles, identify drug repurposing opportunities, flag off-target toxicity risks, and validate targets before costly preclinical work begins. Meta-Flux has demonstrated 97% diagnostic accuracy in sepsis disease modelling and ROC AUC of 0.994 in lung cancer biomarker identification. Founded in 2021 by Lee Sherlock (immunologist, Trinity College) and Brendan Martin (CTO), the company raised a $2.1M seed round in 2025 backed by executives from Pfizer, Merck, and Gilead Sciences.
Summary
Meta-Flux is an Artificial Intelligence company based in Dublin, Ireland, founded in 2024. It has raised $2.1M in total.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company